TRAVERSE Trial of Dupilumab for Severe Oral Corticosteroid-Dependent Asthma
TRAVERSE trial findings on the efficacy, safety, and OCS-sparring effect of dupilumab for severe OCS-dependent asthma were presented at ATS 2022.
All articles by Ron Goldberg
Which Biologics Reduce Allergic Response, Airway Hyperresponsiveness in Asthma?
What biologic therapies effectively treat airway hyperresponsiveness in asthma, and what do these therapies show about the underlying biology of asthma?
New Case-Finding Questionnaire for Undiagnosed Asthma and COPD
Investigators created and validated the Undiagnosed COPD and Asthma Population Questionnaire to overcome limitations of existing case-finding tools.
Switching Inhalers in Patients With Asthma and COPD
Should patients with asthma or COPD have their inhaler regimens switched for nonclinical reasons? A systematic review examined real world evidence on this subject.
Does Depression Influence Asthma Exacerbation Frequency?
To what extent does depression influence asthma exacerbations? A population-based study presented at ATS 2022 examined the link between exacerbations and depression.
Low-Severity COPD: Risk for Exacerbation, Hospitalization, and Death
What is the risk of future COPD exacerbations, hospitalizations, and death among patients with COPD who had 1 or 0 exacerbation in the previous 12 months?
Cigarette and e-Cigarette Transitions and Respiratory Symptoms
What respiratory symptoms are associated with transitions to or from e-cigarettes and cigarettes, and how prevalent are these symptoms?
In COPD, Can Post-Discharge Follow-Up for Exacerbations Improve Outcomes?
In patients with COPD, can multidisciplinary monitoring and follow up post hospital discharge for exacerbation improve quality of life and readmission/mortality rates?
Functional Exercise Capacity in COPD: Are Field Tests Reliable Measures?
In patients with COPD, can functional exercise capacity be reliably measured using field tests such as the incremental shuttle walk test and 6-minute walk test?
Bronchial Thermoplasty for Severe Asthma: 5-Year Clinical Trial Outcomes
A clinical trial of bronchial thermoplasty for severe asthma assessed efficacy and safety outcomes up to 5 years post treatment.
- Loading...
Loading...
Next post in Asthma
Loading... 
Loading...